BNP Paribas Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $168M | Sell |
334,433
-305,951
| -48% | -$147M | 0.17% | 117 |
|
|
2026
Q1 | $315M | Sell |
640,384
-70,414
| -10% | -$38.2M | 0.37% | 47 |
|
|
2025
Q4 | $412M | Buy |
+710,798
| New | +$402M | 0.47% | 32 |
|
|
2025
Q3 | – | Sell |
-351,752
| Closed | -$143M | – | 2069 |
|
|
2025
Q2 | $143M | Buy |
351,752
+64,341
| +22% | +$26.9M | 0.35% | 56 |
|
|
2025
Q1 | $143M | Buy |
287,411
+700
| +0.2% | +$379K | 0.38% | 49 |
|
|
2024
Q4 | $149M | Buy |
286,711
+105,910
| +59% | +$58.2M | 0.37% | 57 |
|
|
2024
Q3 | $112M | Buy |
180,801
+7,727
| +4% | +$4.57M | 0.28% | 82 |
|
|
2024
Q2 | $95.7M | Sell |
173,074
-10,082
| -6% | -$5.78M | 0.25% | 90 |
|
|
2024
Q1 | $106M | Buy |
183,156
+1,565
| +0.9% | +$878K | 0.28% | 82 |
|
|
2023
Q4 | $96.4M | Buy |
181,591
+3,147
| +2% | +$1.52M | 0.27% | 91 |
|
|
2023
Q3 | $90.3M | Sell |
178,444
-53,031
| -23% | -$28.3M | 0.28% | 86 |
|
|
2023
Q2 | $121M | Sell |
231,475
-18,571
| -7% | -$10M | 0.37% | 56 |
|
|
2023
Q1 | $144M | Buy |
250,046
+99,278
| +66% | +$56M | 0.5% | 38 |
|
|
2022
Q4 | $83M | Sell |
150,768
-9,418
| -6% | -$4.99M | 0.3% | 82 |
|
|
2022
Q3 | $81.2M | Sell |
160,186
-84,194
| -34% | -$47.1M | 0.32% | 70 |
|
|
2022
Q2 | $133M | Buy |
244,380
+82,456
| +51% | +$45.4M | 0.51% | 35 |
|
|
2022
Q1 | $95.6M | Sell |
161,924
-19,588
| -11% | -$11.3M | 0.33% | 64 |
|
|
2021
Q4 | $121M | Buy |
181,512
+10,379
| +6% | +$6.48M | 0.4% | 50 |
|
|
2021
Q3 | $97.8M | Buy |
171,133
+47,814
| +39% | +$26.2M | 0.36% | 61 |
|
|
2021
Q2 | $62.2M | Buy |
123,319
+27,748
| +29% | +$13.1M | 0.22% | 108 |
|
|
2021
Q1 | $43.6M | Buy |
95,571
+30,308
| +46% | +$14.5M | 0.18% | 136 |
|
|
2020
Q4 | $30.4M | Sell |
65,263
-17,488
| -21% | -$8.2M | 0.14% | 188 |
|
|
2020
Q3 | $36.5M | Sell |
82,751
-1,409
| -2% | -$582K | 0.21% | 126 |
|
|
2020
Q2 | $30.5M | Buy |
84,160
+67,359
| +401% | +$22.6M | 0.21% | 139 |
|
|
2020
Q1 | $4.76M | Sell |
16,801
-11,453
| -41% | -$3.61M | 0.04% | 401 |
|
|
2019
Q4 | $9.18M | Buy |
28,254
+1,970
| +7% | +$597K | 0.06% | 339 |
|
|
2019
Q3 | $7.66M | Buy |
26,284
+1,454
| +6% | +$416K | 0.06% | 354 |
|
|
2019
Q2 | $7.29M | Sell |
24,830
-13,724
| -36% | -$3.78M | 0.06% | 355 |
|
|
2019
Q1 | $10.6M | Sell |
38,554
-32,631
| -46% | -$8.12M | 0.09% | 284 |
|
|
2018
Q4 | $15.8M | Buy |
71,185
+28,194
| +66% | +$6.61M | 0.15% | 193 |
|
|
2018
Q3 | $10.5M | Sell |
42,991
-15,935
| -27% | -$3.67M | 0.08% | 327 |
|
|
2018
Q2 | $12.2M | Buy |
58,926
+5,112
| +9% | +$1.09M | 0.1% | 289 |
|
|
2018
Q1 | $11.1M | Sell |
53,814
-22,831
| -30% | -$4.79M | 0.09% | 305 |
|
|
2017
Q4 | $14.6M | Sell |
76,645
-87,185
| -53% | -$16.7M | 0.12% | 237 |
|
|
2017
Q3 | $31M | Sell |
163,830
-54,433
| -25% | -$9.86M | 0.26% | 85 |
|
|
2017
Q2 | $38.1M | Sell |
218,263
-11,680
| -5% | -$1.96M | 0.34% | 66 |
|
|
2017
Q1 | $35.3M | Sell |
229,943
-8,975
| -4% | -$1.37M | 0.32% | 69 |
|
|
2016
Q4 | $33.7M | Sell |
238,918
-72,231
| -23% | -$10.6M | 0.32% | 73 |
|
|
2016
Q3 | $49.5M | Sell |
311,149
-67,692
| -18% | -$10.4M | 0.42% | 50 |
|
|
2016
Q2 | $56M | Sell |
378,841
-38,351
| -9% | -$5.66M | 0.47% | 41 |
|
|
2016
Q1 | $59.1M | Buy |
417,192
+66,663
| +19% | +$8.93M | 0.5% | 39 |
|
|
2015
Q4 | $49.7M | Buy |
350,529
+37,698
| +12% | +$5.03M | 0.42% | 50 |
|
|
2015
Q3 | $38.3M | Buy |
312,831
+214,518
| +218% | +$27.9M | 0.34% | 66 |
|
|
2015
Q2 | $12.8M | Buy |
98,313
+34,791
| +55% | +$4.54M | 0.1% | 275 |
|
|
2015
Q1 | $8.53M | Buy |
63,522
+14,529
| +30% | +$1.87M | 0.07% | 358 |
|
|
2014
Q4 | $6.14M | Sell |
48,993
-30,394
| -38% | -$3.7M | 0.05% | 396 |
|
|
2014
Q3 | $9.66M | Buy |
79,387
+32,805
| +70% | +$3.99M | 0.08% | 287 |
|
|
2014
Q2 | $5.5M | Buy |
46,582
+58
| +0.1% | +$6.83K | 0.04% | 437 |
|
|
2014
Q1 | $5.59M | Buy |
46,524
+96
| +0.2% | +$11.4K | 0.04% | 410 |
|
|
2013
Q4 | $5.17M | Buy |
46,428
+3,577
| +8% | +$356K | 0.04% | 392 |
|
|
2013
Q3 | $3.95M | Sell |
42,851
-5,946
| -12% | -$538K | 0.03% | 428 |
|
|
2013
Q2 | $4.13M | Buy |
+48,797
| New | +$4.06M | 0.03% | 454 |
|
Other funds holding TMO
BNP Paribas Asset Management's TMO Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 48% in Q2 2026, selling an estimated $147M and leaving 334,433 shares worth $168M. The position accounts for 0.17% of the portfolio, ranked #117.
BNP Paribas Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $412M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- BNP Paribas Asset Management held 334,433 shares of Thermo Fisher Scientific worth $168M as of Q2 2026.
- BNP Paribas Asset Management sold 305,951 Thermo Fisher Scientific shares in Q2 2026, an estimated $147M.
- Thermo Fisher Scientific made up 0.17% of BNP Paribas Asset Management's portfolio in Q2 2026, its #117 holding.
- BNP Paribas Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Asset Management's Thermo Fisher Scientific position peaked at $412M in Q4 2025.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.